RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1093%2Feurheartj%2Fehaa802

https://w3id.org/ripe/ripe-kg/work/10.1093%2Feurheartj%2Fehaa802
SubjectPredicateObject
ripekg:publication-details/RIPEAEFF3EFFF7777967ACell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> ripe:concerns ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i>
ripekg:registry-evidence/RIPEAEFF3EFFF7777967A ripe:concerns ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i>
ripekg:research-integrity-assessment/RIPEAEFF3EFFF7777967A ripe:assesses ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i>
ripekg:study-design-evidence/RIPEAEFF3EFFF7777967A ripe:concerns ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i>
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> prism:doi 10.1093/eurheartj/ehaa802
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU0F9CF0B1B442EC62Jozef Bartunek
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU185C36CBC75AD8EDMarie-Claire Good
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU30F85BF578AB73E7John Martin
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU335A94F898FCF6C8Christine Hauskeller
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU5046D84C55115E13Jens Kastrup
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU63FDC17ECA0E7814Ricardo Sanz-Ruiz
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU6FA9CAA1F7A3D285Anthony Mathur
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU7EEC68109CF3E12ASeppo Yla ¨-Herttuala
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU8640D33970351085Manuel Galiñanes
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU8BEAAA991AF27FE8Petr Kala
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU8D8720011FD18830Filippo Crea
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAU914007E2042ED0AAPhilippe Menasche
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAUAEF60130B2A2C64EStefan Janssens
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAUB9D8538BEE582873Sheik Dowlut
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAUBB77873BFC06FD5CFrancisco Ferna ´ndez-Avile
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAUCF1B6BB05A068D18Juha Hartikainen
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAUD70772C6AC39B2BAInterventional Cardiology
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAUE65D224A38B2A86AAndreas Zeiher
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:creator ripekg:author/RIPEAUEB6AF47563958859Ann Belmans
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> dcterms:title Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i>
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW0A91042AF1421353Autologous CD34þ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW1E965DCECAEA68EFThe consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW353A365A5C6184CDRandomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW4041A40E81BA8179Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW446C2D692EB8D834The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW54C99787F47FD821The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG) Medicare-linked database
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW5C62958155C3F108Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW627D6B7CC724CF13REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW876FD50DD803984AEstimation statistics should replace significance testing
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEW92C8766D61427213Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEWB5E91CA4E6D7F050Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus > _ 40% (from the HORIZONS-AMI trial)
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEWB8E827D15E9F7C36Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEWC2D6A123D3CDFB2EHeart failure adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters a systematic review and metaanalysis
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEWD532CE1B2515D657The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEWE3E81967B7DC0760Trust discrete sequential boundaries for clinical trials
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEWEBF72C445305E064harmonization and cultural differences: examining the implementation of a European Stem
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> http://purl.org/spar/cito/cites ripekg:work/RIPEWF3CA359F33F8AF6CThe prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> rdf:type node1
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> rdf:type rdfs:Resource
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> rdf:type owl:Thing
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> rdf:type prov:Entity
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> rdf:type ripe:WorkWork
ripekg:work/10.1093%2Feurheartj%2Fehaa802Cell therapy for acute myocardial infarction: <i>Requiescat in Pace</i> owl:sameAs https://semopenalex.org/work/W3094493757